InspireMD (NYSEAMERICAN:NSPR) Trading Down 1.6%
InspireMD (NYSEAMERICAN:NSPR) Trading Down 1.6%
InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating)'s stock price fell 1.6% on Monday . The company traded as low as $1.79 and last traded at $1.80. 5,429 shares changed hands during trading, a decline of 77% from the average session volume of 23,743 shares. The stock had previously closed at $1.83.
InSpireMD,Inc.(NYSEAMERICAN:NSPR-GET Rating)周一股价下跌1.6%。该公司股价最低跌至1.79美元,最新报1.80美元。交易中有5,429股易手,较23,743股的平均成交量下跌77%。该股此前收盘报1.83美元。
InspireMD Stock Performance
InspirreMD股票表现
The company has a market capitalization of $14.98 million, a price-to-earnings ratio of -0.60 and a beta of 1.51.
该公司市值为1,498万美元,市盈率为-0.60倍,贝塔系数为1.51。
InspireMD (NYSEAMERICAN:NSPR – Get Rating) last posted its quarterly earnings results on Tuesday, August 9th. The medical equipment provider reported ($0.59) earnings per share for the quarter. InspireMD had a negative return on equity of 43.80% and a negative net margin of 448.33%. The company had revenue of $1.53 million for the quarter.
InSpireMD(NYSEAMERICAN:NSPR-GET Rating)最近一次公布季度收益结果是在8月9日,星期二。这家医疗设备提供商公布了本季度每股收益(0.59美元)。InSpireMD的净资产回报率为负43.80%,净利润率为负448.33%。该公司本季度的收入为153万美元。
Insider Activity at InspireMD
InSpireMD的内幕活动
Institutional Investors Weigh In On InspireMD
机构投资者参与InspirreMD
A hedge fund recently bought a new stake in InspireMD stock. Millennium Management LLC purchased a new stake in InspireMD, Inc. (NYSEAMERICAN:NSPR – Get Rating) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 14,191 shares of the medical equipment provider's stock, valued at approximately $28,000. Millennium Management LLC owned 0.17% of InspireMD as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 2.09% of the company's stock.
一家对冲基金最近购买了InSpireMD股票的新股份。根据千禧管理公司在最近提交给美国证券交易委员会的13F文件中,该公司在第二季度购买了InSpireMD,Inc.(NYSEAMERICAN:NSPR-GET Rating)的新股份。该公司购买了这家医疗设备提供商的14,191股股票,价值约28,000美元。截至最近提交给美国证券交易委员会(Securities&Exchange Commission)的文件,Millennium Management LLC持有InspirreMD 0.17%的股份。机构投资者持有该公司2.09%的股票。
About InspireMD
关于InspirreMD
(Get Rating)
(获取评级)
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery.
InspirreMD公司是一家医疗设备公司,专注于开发专有的MicroNet支架平台技术并将其商业化,用于治疗欧洲、拉丁美洲、中东和亚太地区的血管和冠状动脉疾病。该公司提供用于颈动脉应用的CGuard颈动脉血栓预防系统,以及用于急性冠脉综合征患者的MGuard Prime血栓保护系统,特别是急性心肌梗死、大隐静脉移植冠状动脉介入治疗以及搭桥手术。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on InspireMD (NSPR)
- 3 Downgraded Must-Have Stocks To Put On Your Watchlist
- This Is What To Expect From The Q3 Earnings Reporting Season
- 3 Biotech Stocks Gaining Momentum
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- 免费获取StockNews.com关于InspirreMD的研究报告(NSPR)
- 3只被降级的必备股票放在你的观察名单上
- 这是对第三季度收益报告季节的预期
- 3只生物科技股势头强劲
- 电子艺界能扭转电子游戏市场的低迷吗?
- 美元将军是美国小池塘里的大鱼。
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
接受《InspirreMD日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对InSpireMD和相关公司的最新新闻和分析师评级的每日简要摘要。